Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Shuntaro Obi
Observed names:
Obi Shuntaro,
Obi, S.,
Obi, Shuntaro,
S Obi,
S. Obi,
Shun'taro Obi,
Shuntaro OBI,
小尾 俊太郎,
小尾, 俊太郎
show all 9
Institutions:
Teikyo University Chiba Medical Center,
Yamanashi Prefectural Central Hospital,
Yamanashi Hospital
Observed institutions:
Boston University,
Sasaki Institute,
Teikyo University Hospital,
University of Tokyo Hospital,
Teikyo University Chiba Medical Center,
Yamanashi Prefectural Central Hospital,
Yamanashi Hospital,
The University of Tokyo,
Teikyo University,
Kindai University
show all 10
ORCID:
0000-0003-3525-4708
Observed ORCID:
0000-0003-3525-4708
OpenAlex ID:
A5030763210
Asia–Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update
2017
·
Masao Omata
, Ann-Lii Cheng
, et al.
·
Hepatology International
·
2,172
PDF
Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinoma
2010
·
Masao Omata
, Laurentius A. Lesmana
, et al.
·
Hepatology International
·
1,026
PDF
A Randomized Controlled Trial of Radiofrequency Ablation With Ethanol Injection for Small Hepatocellular Carcinoma
2005
·
Shuichiro Shiina
, Takuma Teratani
, et al.
·
Gastroenterology
·
877
PDF
Percutaneous radiofrequency ablation for hepatocellular carcinoma
2005
·
Ryosuke Tateishi
, Shuichiro Shiina
, et al.
·
Cancer
·
778
Radiofrequency ablation for hepatocellular carcinoma in so-called high-risk locations
2006
·
Takuma Teratani
, Haruhiko Yoshida
, et al.
·
Hepatology
·
331
PDF
Des-?-carboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma
2001
·
Yukihiro Koike
, Yasushi Shiratori
, et al.
·
Cancer
·
310
PDF
Sorafenib plus low-dose cisplatin and fluorouracil hepatic arterial infusion chemotherapy versus sorafenib alone in patients with advanced hepatocellular carcinoma (SILIUS): a randomised, open label, phase 3 trial
2018
·
Masatoshi Kudo
, Kazuomi Ueshima
, et al.
·
The Lancet. Gastroenterology & hepatology
·
305
Interferon Therapy after Tumor Ablation Improves Prognosis in Patients with Hepatocellular Carcinoma Associated with Hepatitis C Virus
2003
·
Yasushi Shiratori
, Shuichiro Shiina
, et al.
·
Annals of Internal Medicine
·
274
Combination therapy of intraarterial 5‐fluorouracil and systemic interferon‐alpha for advanced hepatocellular carcinoma with portal venous invasion
2006
·
Shuntaro Obi
, Haruhiko Yoshida
, et al.
·
Cancer
·
262
PDF
Nonsurgical Treatment of Hepatocellular Carcinoma: From Percutaneous Ethanol Injection Therapy and Percutaneous Microwave Coagulation Therapy to Radiofrequency Ablation
2002
·
Shuichiro Shiina
, Takuma Teratani
, et al.
·
Oncology
·
183
Prediction of recurrence of hepatocellular carcinoma after curative ablation using three tumor markers
2006
·
Ryosuke Tateishi
, Shuichiro Shiina
, et al.
·
Hepatology
·
154
PDF
Extrahepatic metastasis of hepatocellular carcinoma: incidence and risk factors
2008
·
Miho Kanda
, Ryosuke Tateishi
, et al.
·
Liver International
·
147
Risk Factors for Recurring Hepatocellular Carcinoma Differ According to Infected Hepatitis Virus—An Analysis of 236 Consecutive Patients With A Single Lesion
2000
·
Yukihiro Koike
, Yasushi Shiratori
, et al.
·
Hepatology
·
131
Current Status of Hepatic Arterial Infusion Chemotherapy
2015
·
Shuntaro Obi
, Shinpei Sato
, et al.
·
Liver Cancer
·
120
PDF
Hepatic Arterial Infusion Chemotherapy versus Sorafenib in Patients with Advanced Hepatocellular Carcinoma
2020
·
Kazuomi Ueshima
, Sadahisa Ogasawara
, et al.
·
Liver Cancer
·
112
PDF
Neoplastic Seeding After Radiofrequency Ablation for Hepatocellular Carcinoma
2008
·
Jun Imamura
, Ryosuke Tateishi
, et al.
·
The American Journal of Gastroenterology
·
111
Randomized phase II study of axitinib versus placebo plus best supportive care in second-line treatment of advanced hepatocellular carcinoma
2015
·
Y.-K. Kang
, T. Yau
, et al.
·
Annals of Oncology
·
103
PDF
A phase I/II trial of the oral antiangiogenic agent TSU-68 in patients with advanced hepatocellular carcinoma
2010
·
Fumihiko Kanai
, Haruhiko Yoshida
, et al.
·
Cancer Chemotherapy and Pharmacology
·
98
MicroRNA-140 acts as a liver tumor suppressor by controlling NF-κB activity by directly targeting DNA methyltransferase 1 (Dnmt1) expression
2012
·
Akemi Takata
, Motoyuki Otsuka
, et al.
·
Hepatology
·
92
PDF
Percutaneous ethanol injection for hepatocellular carcinoma: 20‐year outcome and prognostic factors
2012
·
Shuichiro Shiina
, Ryosuke Tateishi
, et al.
·
Liver International
·
84
PDF
Ultrasound surveillance for early detection of hepatocellular carcinoma among patients with chronic hepatitis C
2009
·
Takahisa Sato
, Ryosuke Tateishi
, et al.
·
Hepatology International
·
84
PDF
APASL clinical practice guidelines on systemic therapy for hepatocellular carcinoma-2024
2024
·
George Lau
, Shuntaro Obi
, et al.
·
Hepatology International
·
75
Absence of PIK3CA hotspot mutations in hepatocellular carcinoma in Japanese patients
2005
·
Y Tanaka
, F Kanai
, et al.
·
Oncogene
·
74
Unique clinical characteristics of patients with hepatocellular carcinoma who present with high plasma des-?-carboxy prothrombin and low serum ?-fetoprotein
2000
·
Keisuke Hamamura
, Yasushi Shiratori
, et al.
·
Cancer
·
69
PDF
Congenital absence of portal vein with multiple hyperplastic nodular lesions in the liver
2003
·
Yasuo Tanaka
, Masaki Takayanagi
, et al.
·
Journal of Gastroenterology
·
57
Show more works
View as search
Works count:
158
Citation count:
9,499
H-index:
37
I10-index:
66
Year
Topic
Type
